The US Army has awarded Saab an indefinite-delivery, indefinite-quantity (IDIQ) contract worth up to USD 494 million (EUR 447 million) over five years for orders placed under the army’s XM919 Individual Assault Munition (IAM) programme.
Saab’s solution for the programme is the Confined Space Tandem Warhead version of its AT4 anti-armour weapon (AT4CS TW). This new addition to the battle-tested AT4 family combines the capability of multiple existing shoulder-launched munitions while reducing soldier load, training complexity and the weapon’s logistics burden, according to Saab.
“At Saab we continually adapt and improve our products to meet customer needs and protect the warfighter. Our new IAM solution enhances capabilities, removes combat burdens and is uniquely created to meet the US customer’s needs,” Erik Smith, president and CEO of Saab’s US operation, was quoted as saying in a company press release. “Saab has leveraged a successful, combat-proven system to make it even more effective, ultimately ensuring our solution is the best fit for the end-user,” he added.
More than a million AT4 systems have been produced for 15 countries around the world, according to Saab. Lightweight, manportable, and fully disposable, the AT4 has been a US Army squad weapon since 1985.
Saab has delivered more than 700,000 AT4 systems to the United States.
